Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Liposarcoma, Myxoid × Trabectedin × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 7 Solitary Fibrous Tumors 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Recurrent High Grade Meningioma 1 Recurrence 1 Ovarian Neoplasms 1 Liposarcoma, Myxoid 1 Liposarcoma 1 Leiomyosarcoma Uterus 1 Histiocytoma, Malignant Fibrous 1 Hemangioendothelioma 1

Interventions

Cyclophosphamide 3 fludarabine 2 selinexor 1 pembrolizumab 1 pazopanib 1 palbociclib 1 mirdametinib 1 fludarabine phosphate 1 X-Rays 1 Trabectedin 1 Specimen Handling 1 Proton Therapy 1 Pioglitazone 1 Phantoms, Imaging 1 Magnetic Resonance Spectroscopy 1 Leukapheresis 1 Ifosfamide 1 Doxorubicin 1 ALT-803 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04794127 2026-02-18

TRABEPIO

Mario Negri Institute for Pharmacological Research

Phase 2 Completed

Liposarcoma, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡